Lataa...

Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy

Tocilizumab is a humanized antihuman interleukin-6 (IL-6) receptor monoclonal antibody. It was developed in Japan as the first biological disease-modifying antirheumatic drug targeting IL-6 receptors. Many large-scale global studies have demonstrated its efficacy and safety, and in April 2008 it was...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijä: Kaneko, Atsushi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publications 2013
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539265/
https://ncbi.nlm.nih.gov/pubmed/23342244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622312466908
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!